STCube rises 6.87% amid immune checkpoint inhibitor theme uptrend

On the 10th, the immuno-oncology theme rose 3.09% compared to the previous day, showing strength, while STCube, a related stock attracting attention, surged 6.87% compared to the previous day. STCube is known as a developer of robot control modules and new anticancer drug candidate substances.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme



According to provisional data compiled at 10:26, foreigners are net buying 0.43 ten thousand shares of STCube.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: Ten Thousand Shares)



According to the analysis by Thinkpool RoboAlgorithm RASSI, STCube’s quant financial score is 7.51 points, with higher growth and stability scores than the average of other immuno-oncology related stocks, but its quant financial ranking was only 13th out of 25 stocks. On the other hand, Dong-A ST ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top Stocks by Financial Scores within the Theme


※ The quant financial score is the result of RoboAlgorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.